Humanigen Inc (HGENQ)

[rstar]

biggest problem for lily/ regeneron is when one has covid and not severe- they will not go to the hospital for an infusion. Ive talked to friends , family who have had covid and they all agree- last place they want to go is hospital if they don't have to. docs not offering those drugs to them either. Lenz -, once data proves out, is used once they have ended up in the hospital- where both Lily and Regeneron have FAILED in their tests for severe covid- they only work at the phase of covid where most will not seek them out, but failed when covid symptoms get more severe, where Lenz looks like it is the most effective drug. the market will realize all this soon.